Transforming growth factor-?1 remodels the cytoskeleton organization of mature dendritic cells via Smad2/3 signaling pathway

被引:0
|
作者
Yang H. [1 ]
Long J. [1 ]
Wang Y. [1 ,3 ]
Hu W. [1 ]
Hu Z. [1 ]
Zhou J. [1 ]
Liu L. [1 ]
Qiu W. [1 ]
Tang F. [1 ]
Yao W. [4 ]
Li L. [5 ]
Zeng Z. [1 ,2 ,6 ]
机构
[1] Immune Cells and Antibody Engineering Research Center of Guizhou Province, Key Laboratory of Biology and Medical Engineering, Guizhou Medical University, Guiyang
[2] School of Biology and Engineering, Guizhou Medical University, Guiyang
[3] Department of Head and Neck, Affiliated Cancer Hospital, Guizhou Medical University, Guiyang
[4] Hemorheology Center, School of Basic Medical Sciences, Health Science Center of Peking University, Beijing
[5] Department of Nephrology, Third Affiliated Hospital of Guizhou Medical University, Duyun, Guizhou Province
[6] Key Laboratory of Environmental Pollution and Disease Surveillance and Control of Ministry of Education, Guiyang
来源
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Immune function; Mature dendritic cells; Motility; Smad sigling pathway; Transforming growth factor ?1;
D O I
10.3970/mcb.2018.015.021
中图分类号
学科分类号
摘要
Dendritic cells (DCs) are the most potent professional antigen presenting cells as now known, which play critical roles in the initiation, programming and regulation of the immune response. Transforming growth factor-?1 (TGF-?1), one of the major suppressive cytokines in tumor microenvironment, can deteriorate the biomechanical characteristics and motility of mature dendritic cells (mDCs)?but the underlying molecular mechanisms are not well defined. In this study, the effects of TGF-?1 on the motilities and T cell priming capabilities of mDCs as well as the molecular regulatory mechanisms were investigated. The results showed that the cytoskeleton (F-actin) organizations of mDCs were abnormally remodeled by TGF-?1. Simultaneously, the migration and immune priming capabilities of mDCs were impaired by TGF-?1 via Smad2/3 signaling pathway. It's significant for further understanding the interaction of DCs and TGF-?1 in tumor host, as well as the immune escape mechanism of cancer, which may be important for enhancing the clinical efficiency of DCs-based immunotherapy against cancer. Copyright © 2018 Tech Science Press
引用
收藏
页码:21 / 36
页数:15
相关论文
共 50 条
  • [1] Honokiol Alleviates Hypertrophic Scar by Targeting Transforming Growth Factor-β/Smad2/3 Signaling Pathway
    Zhao, Danyang
    Wang, Yu
    Du, Chao
    Shan, Shengzhou
    Zhang, Yifan
    Du, Zijing
    Han, Dong
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [2] The Smad pathway in transforming growth factor-β signaling
    Haiyan Lin
    Hongmei Wang
    Cheng Zhu
    Science in China Series C: Life Sciences, 2003, 46 : 449 - 463
  • [3] The Smad pathway in transforming growth factor-β signaling
    Lin, HY
    Wang, HM
    Zhu, C
    SCIENCE IN CHINA SERIES C-LIFE SCIENCES, 2003, 46 (05): : 449 - 463
  • [4] The Smad pathway in transforming growth factor-β signaling
    林海燕
    王红梅
    祝诚
    Science in China(Series C:Life Sciences), 2003, (05) : 449 - 463
  • [5] Baicalein attenuates hypertrophic scar formation via inhibition of the transforming growth factor-β/Smad2/3 signalling pathway
    Zhang, Y. F.
    Zhou, S. Z.
    Cheng, X. Y.
    Yi, B.
    Shan, S. Z.
    Wang, J.
    Li, Q. F.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 174 (01) : 120 - 130
  • [6] RAP250 is a coactivator in the transforming growth factor β signaling pathway that interacts with smad2 and smad3
    Antonson, Per
    Jakobsson, Tomas
    Almloef, Tova
    Guldevall, Karolin
    Steffensen, Knut R.
    Gustafsson, Jan-Ake
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (14) : 8995 - 9001
  • [7] Direct inhibition of the transforming growth factor-β pathway by protein-bound polysaccharide through inactivation of Smad2 signaling
    Ono, Yoshihiro
    Hayashida, Tetsu
    Konagai, Ayano
    Okazaki, Hiroshi
    Miyao, Kazuhiro
    Kawachi, Shigeyuki
    Tanabe, Minoru
    Shinoda, Masahiro
    Jinno, Hiromitsu
    Hasegawa, Hirotoshi
    Kitajima, Masaki
    Kitagawa, Yuko
    CANCER SCIENCE, 2012, 103 (02) : 317 - 324
  • [8] The transforming growth factor-β/SMAD signaling pathway is present and functional in human mesangial cells
    Poncelet, AC
    de Caestecker, MP
    Schnaper, HW
    KIDNEY INTERNATIONAL, 1999, 56 (04) : 1354 - 1365
  • [9] The oncoprotein ski acts as an antagonist of transforming growth factor-β signaling by suppressing Smad2 phosphorylation
    Prunier, C
    Pessah, M
    Ferrand, N
    Seo, SR
    Howe, P
    Atfi, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (28) : 26249 - 26257
  • [10] Retinol dehydrogenase 10 promotes metastasis of glioma cells via the transforming growth factor-β/SMAD signaling pathway
    Guan, Feng
    Kang, Zhuang
    Wang, Liang
    Wang, Ke
    Mao, Bei-Bei
    Peng, Wei-Cheng
    Zhang, Bo-Lun
    Lin, Zhen-Yang
    Zhang, Jun-Ting
    Hu, Zhi-Qiang
    CHINESE MEDICAL JOURNAL, 2019, 132 (20) : 2430 - 2437